21 April 2017 - - US-based biopharmaceutical company Sorrento Therapeutics, Inc. (NASDAQ: SRNE) has closed an underwritten public offering of 23,625,084 shares of its common stock at a public offering price of USD 2.00 per share, the compan...
21 April 2017 - - US-based medication management programmes specialist Diplomat Pharmacy, Inc. (NYSE: DPLO) has been selected to the specialty pharmacy panel to distribute Zejula (niraparib) for women with recurrent epithelial ovarian, fallopian...
21 April 2017 - - The US Food and Drug Administration has reached an agreement with biopharmaceutical research and development company CytRx Corp. (NASDAQ: CYTR) on preparations for a New Drug Application submission for aldoxorubicin in soft tissue s...
21 April 2017 - - The global botulinum toxin market is expected to reach a value of USD 7.3bn by 2025, according to a new report from Dublin-based Research and Markets.

Research and Markets said that the constant introduction of inn...
21 April 2017 - - The global market was valued at USD 1.051bn in 2015, and is projected to reach USD 1.61bn by 2022, growing at a CAGR of 6.2% from 2016 to 2022, according to a new report from US-based market research and business...